Induction With SVF Derived MSC in Living-related Kidney Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The objective of this trial is to determine if autologous SVF derived MSC can effectively reduce the need for post transplant immunosuppressant in living-relative kidney transplantation. 120 patients eligible for the study as described below will be enrolled, with 60 patients in intervention group and 60 in control group.
Epistemonikos ID: 44ed5c670da6dcab9e6c93cb37b837fd1cf2c826
First added on: May 12, 2024